136 related articles for article (PubMed ID: 10528222)
1. Induction of experimental autoimmune Graves' disease in BALB/c mice.
Kaithamana S; Fan J; Osuga Y; Liang SG; Prabhakar BS
J Immunol; 1999 Nov; 163(9):5157-64. PubMed ID: 10528222
[TBL] [Abstract][Full Text] [Related]
2. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor.
Arima T; Shimojo N; Yamaguchi K; Tomiita M; Kohn LD; Kohno Y
Clin Immunol; 2008 Apr; 127(1):7-13. PubMed ID: 18234558
[TBL] [Abstract][Full Text] [Related]
5. Development of an animal model of autoimmune thyroid eye disease.
Many MC; Costagliola S; Detrait M; Denef F; Vassart G; Ludgate MC
J Immunol; 1999 Apr; 162(8):4966-74. PubMed ID: 10202044
[TBL] [Abstract][Full Text] [Related]
6. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
[TBL] [Abstract][Full Text] [Related]
7. Role of natural killer T cells in Graves' disease.
Luo W; Guo H; Aosai F; Yano A
Chin Med J (Engl); 2002 Aug; 115(8):1183-5. PubMed ID: 12215288
[TBL] [Abstract][Full Text] [Related]
8. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease.
Kita M; Ahmad L; Marians RC; Vlase H; Unger P; Graves PN; Davies TF
Endocrinology; 1999 Mar; 140(3):1392-8. PubMed ID: 10067867
[TBL] [Abstract][Full Text] [Related]
9. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice.
Kaneda T; Honda A; Hakozaki A; Fuse T; Muto A; Yoshida T
Endocrinology; 2007 May; 148(5):2335-44. PubMed ID: 17255207
[TBL] [Abstract][Full Text] [Related]
10. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
[TBL] [Abstract][Full Text] [Related]
11. Distinct role of T helper Type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds.
Horie I; Abiru N; Saitoh O; Ichikawa T; Iwakura Y; Eguchi K; Nagayama Y
Autoimmunity; 2011 Mar; 44(2):159-65. PubMed ID: 20670120
[TBL] [Abstract][Full Text] [Related]
12. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination.
Rao PV; Watson PF; Weetman AP; Carayanniotis G; Banga JP
Endocrinology; 2003 Jan; 144(1):260-6. PubMed ID: 12488353
[TBL] [Abstract][Full Text] [Related]
13. Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice.
Nakahara M; Johnson K; Eckstein A; Taguchi R; Yamada M; Abiru N; Nagayama Y
Endocrinology; 2012 Apr; 153(4):2034-42. PubMed ID: 22334716
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 10 deficiency attenuates induction of anti-TSH receptor antibodies and hyperthyroidism in a mouse Graves' model.
Ueki I; Abiru N; Kawagoe K; Nagayama Y
J Endocrinol; 2011 Jun; 209(3):353-7. PubMed ID: 21474590
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor.
Patibandla SA; Fan JL; Prabhakar BS; Seetharamaiah GS
J Autoimmun; 1999 Sep; 13(2):205-13. PubMed ID: 10479389
[TBL] [Abstract][Full Text] [Related]
16. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
Baker G; Mazziotti G; von Ruhland C; Ludgate M
Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of autoimmune thyroiditis by a single low dose of whole-body irradiation in non-obese diabetic-H2h4 mice.
Nagayama Y; Kaminoda K; Mizutori Y; Saitoh O; Abiru N
Int J Radiat Biol; 2008 Sep; 84(9):761-9. PubMed ID: 18821390
[TBL] [Abstract][Full Text] [Related]
18. Yersinia enterocolitica envelope proteins that are crossreactive with the thyrotropin receptor (TSHR) also have B-cell mitogenic activity.
Zhang H; Kaur I; Niesel DW; Seetharamaiah GS; Peterson JW; Justement LB; Prabhakar BS; Klimpel GR
J Autoimmun; 1996 Aug; 9(4):509-16. PubMed ID: 8864826
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice.
Chen CR; Aliesky H; Pichurin PN; Nagayama Y; McLachlan SM; Rapoport B
Endocrinology; 2004 Nov; 145(11):4927-33. PubMed ID: 15284197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
